The Alternating Current Breakthrough
Initial attempts with direct-current (DC) electrolysis on aminocyclopropanes yielded frustrating results: a mere 20% yield limited to p-methoxy substrates, while electron-deficient analogs remained unreacted. Electrode passivation (graphite anodes coated with insulating films) and uncontrolled polymerization of intermediates stifled progress. Substantial progress eluded us for nearly a year.
A mentor’s suggestion shifted the paradigm: "Try alternating current." After exhaustive optimization, rapid alternating polarity (rAP) at 0.5 Hz with an 80% duty cycle (+2.2 V/−0.7 V) became the linchpin. This approach prevented insulating buildup on graphite felt anodes—unlike DC, which caused it—while trifluoromethanesulfonic acid (HOTf) and acetic anhydride (Ac2O) synergize to stabilize intermediates and promote reversible eliminations. This unlocked trioxygenation of diverse arylcyclopropanes, including drug derivatives like probenecid (anti-gout) and adapalene (acne treatment), in up to 68% yield. Even challenging substituted aminocyclopropanes and heterocyclic substrates (furan/thiophene) proved compatible. The key? Our "Olefin Slow-Release Pool" (OSRP) strategy, where transient olefins act as reservoirs, enabling iterative oxidations without overreaction or polymerization.
Serendipity Strikes Twice
Two unexpected discoveries propelled us further:
The Chlorination Surprise: While probing nucleophiles, adding excess chlorinating agents (DCDMH/ClSO3H) yielded N-(2,2,3-trichloro-1-hydroxypropyl)amides—scaffolds with potential as antiepileptic agents. Optimization delivered trichlorohydroxylated products in up to 91% yield, even on heterocycles like quinoline. Remarkably, both N- and O-protected aminocyclopropanes performed well, and alkyl amide variants also proved competent. Under these conditions, α-amino alcohols could readily undergo substitution by various nucleophiles in one pot. Replacing the chlorine source with a brominating agent (DBDMH) similarly enabled tribromohydroxylation.
Oxygen’s “Cut-and-Sew”: When aryl-substituted aminocyclopropanes reacted under ambient air, we serendipitously isolated a 6,6-fused bicyclic product. Mechanistic analysis revealed O2 as both oxidant and oxygen source, forging four bonds via Mn(II)-catalyzed Hock rearrangement. This evolved into a general method for skeletal editing of drug motifs like ibuprofen.
Pushing to Tetrafunctionalization
Trioxygenation was just the start. Merging electrophotocatalysis (EPC) with HAT mediators (e.g., benzophenone) overcame C–H inertness, achieving the first tetraoxygenation of aminocyclopropanes. Cyclobutanes required higher potentials for tetraoxygenation. Cerium(III) acetate lowered redox potentials, and iodine-mediated "O-insertion" unexpectedly constructed tetrahydrofuro[2,3-d]oxazole cores—a testament to unpredictable reaction pathways.
Why This Matters
Our programmable platform—toggling between DC, rAP, and EPC—offers unprecedented synthetic modularity:
Drug Diversification: Achieved late-stage multifunctionalization of drug-derived cyclopropanes, synthesizing compounds with pharmaceutical potential. N-(2,2,3-trichloro-1-hydroxypropyl)amides have been reported to exhibit antiepileptic drug activity.
Sustainable Activation: Electricity replaces stoichiometric oxidants; nucleophiles (H2O, AcOH) are eco-friendly.
Diverse Nucleophiles: Acetate, water, halogens (Cl, Br), enabling oxazolines, polyols, polyhalogenated alcohols.
Molecular Editing: Accessing high-oxidation-state architectures like tetrahalohydroxylated amides or intricate bicyclic scaffolds.
Mechanistic Validation
OSRP Confirmed: Key olefin intermediates were trapped, and slow infusion boosted yields.
Alternating Polarity Matters: rAP outperformed DC by preventing anode corrosion.
Oxygen’s Role: 18O2 labeling confirmed O2 as the oxygen source in Mn-mediated bicyclization.
DFT Insights: Calculations revealed lower barriers for intramolecular H-transfer vs. elimination, rationalizing OSRP efficiency.
Reflections and Future Horizons
This project was a testament to mechanistic curiosity. The OSRP hypothesis emerged from puzzling over why reactions stalled after two bond activations. Experimentally, optimizing rAP conditions was arduous—electrode corrosion initially plagued scalability. But seeing alternating polarity preserve anode integrity was a eureka moment. The patient guidance and professionalism of mentors played a crucial role in advancing the experimental process, and as the work progressed, we became increasingly familiar with the reaction system, leading to smoother execution.
Looking ahead, we’re exploring:
Broader Substrate Scope: Including unactivated aliphatic strained rings.
Asymmetric Versions: Enantioselective electrochemical editing.
Biological Applications: Leveraging these scaffolds for drug discovery.
Final Thought: Electrochemistry’s precision, coupled with mechanistic design, can unlock reactivity "blind spots." We hope this work inspires further exploration of programmable bond activations in complex molecules.
In summary, as articulated in our paper: “Beyond addressing the long-standing limitations of conventional difunctionalization, this work offers a unified and sustainable platform for programmable C–H and C–C bond activation, expanding the synthetic logic of strain-release chemistry. More broadly, it illustrates that coupling electrochemical precision with mechanistic design can open opportunities for molecular editing in selected cases, enabling access to densely functionalized frameworks that are difficult to obtain by classical methods, albeit at an exploratory stage. We envision that the conceptual and practical advances reported here will inspire further innovations in the selective activation of unactivated bonds and the strategic remodeling of molecular skeletons across complex chemical space.”